
Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

Heihe Cold-Area Car Testing Index Released: Anchoring Global Innovation Hubs, Showcasing the Thriving Power of the Industry
